Scott Wagner - 08 Nov 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Interim Chief Executive Officer
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner
Issuer symbol
GDRX
Transactions as of
08 Nov 2024
Transactions value $
-$180,316
Form type
4
Date filed
12 Nov 2024, 17:37
Previous filing
08 Oct 2024
Next filing
09 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +70.6K +32.16% 290K 08 Nov 2024 Direct F1
transaction GDRX Class A Common Stock Tax liability -$180K -35.8K -12.33% $5.04 254K 08 Nov 2024 Direct
holding GDRX Class A Common Stock 183K 08 Nov 2024 By Wagner Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -70.6K -50% $0.00 70.6K 08 Nov 2024 Class A Common Stock 70.6K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
F3 The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.

Remarks:

Interim Chief Executive Officer